Jeremy M. Boss

This study shows that entinostat enhances CD8+ T cell responses in tumors but only when administered during a specific window after T cell activation, and this effect can be restored by prior oncolytic virus treatment.

This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.

The paper investigates the role of MHCII reduction in protecting mice from alpha-synuclein-induced degeneration and finds that it is insufficient, while showing epigenetic regulation of the Parkinson's HLA locus.